Saltar al contenido
Merck

Influence of mycotoxins and a mycotoxin adsorbing agent on the oral bioavailability of commonly used antibiotics in pigs.

Toxins (2012-05-19)
Joline Goossens, Virginie Vandenbroucke, Frank Pasmans, Siegrid De Baere, Mathias Devreese, Ann Osselaere, Elin Verbrugghe, Freddy Haesebrouck, Sarah De Saeger, Mia Eeckhout, Kris Audenaert, Geert Haesaert, Patrick De Backer, Siska Croubels
RESUMEN

It is recognized that mycotoxins can cause a variety of adverse health effects in animals, including altered gastrointestinal barrier function. It is the aim of the present study to determine whether mycotoxin-contaminated diets can alter the oral bioavailability of the antibiotics doxycycline and paromomycin in pigs, and whether a mycotoxin adsorbing agent included into diets interacts with those antibiotics. Experiments were conducted with pigs utilizing diets that contained blank feed, mycotoxin-contaminated feed (T-2 toxin or deoxynivalenol), mycotoxin-contaminated feed supplemented with a glucomannan mycotoxin binder, or blank feed supplemented with mycotoxin binder. Diets with T-2 toxin and binder or deoxynivalenol and binder induced increased plasma concentrations of doxycycline administered as single bolus in pigs compared to diets containing blank feed. These results suggest that complex interactions may occur between mycotoxins, mycotoxin binders, and antibiotics which could alter antibiotic bioavailability. This could have consequences for animal toxicity, withdrawal time for oral antibiotics, or public health.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Paromomycin sulfate salt, ≥98% (TLC)
Sigma-Aldrich
Paromomycin sulfate salt, powder, BioReagent, suitable for cell culture, potency: ≥675 μg per mg
Sigma-Aldrich
Paromomycin sulfate salt, suitable for plant cell culture, BioReagent